Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Transplant Cell Ther. 2022 Dec 13;29(3):206.e1–206.e7. doi: 10.1016/j.jtct.2022.12.004

Table 1:

Antimicrobial susceptibility testing results of 26 Nocardia isolates

Drugs tested Susceptible (N=26)
Amikacin 24 (92.3)
Augmentin 9 (34.6)
Ceftriaxone 8 (30.8)
Ciprofloxacin 6 (23.1)
Clarithromycin 8 (30.8)
Doxycycline 3 (11.5)
Imipenem 22 (84.6)
Linezolid 26 (100.0)
Minocycline 4 (15.4)
Moxifloxacin 10 (38.5)
Tobramycin 15 (57.7)
Trimethoprim-sulfamethoxazole 25 (96.2)

Data are N (%)